Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessment of 18F-Florbetaben Whole-body PET for the Detection of Cardiac and Extracardiac Sites of Amyloid Deposits (CAPRI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03616496
Recruitment Status : Not yet recruiting
First Posted : August 6, 2018
Last Update Posted : September 4, 2019
Sponsor:
Information provided by (Responsible Party):
Central Hospital, Nancy, France

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : September 20, 2021
Estimated Study Completion Date : November 20, 2021